Assembly Biosciences (ASMB) Cash from Investing Activities Growth (1y) (2013 - 2026)
Assembly Biosciences (ASMB) Cash from Investing Activities Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Assembly Biosciences | 442.79 Mn | 216.19 Mn | - | -181.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -181.72% |
| Dec 31, 2025 | 416.95% |
| Sep 30, 2025 | -746.32% |
| Jun 30, 2025 | 232.76% |
| Mar 31, 2025 | -61.87% |
| Dec 31, 2024 | 92.53% |
| Sep 30, 2024 | 29.70% |
| Jun 30, 2024 | 161.05% |
| Mar 31, 2024 | 72.72% |
| Dec 31, 2023 | -641.32% |
| Sep 30, 2023 | -39.93% |
| Jun 30, 2023 | -187.16% |
| Mar 31, 2023 | -69.74% |
| Dec 31, 2022 | 295.21% |
| Sep 30, 2022 | 56.61% |
| Jun 30, 2022 | 410.88% |
| Mar 31, 2022 | 83.44% |
| Dec 31, 2021 | -140.96% |
| Sep 30, 2021 | 140.23% |
| Jun 30, 2021 | -104.03% |